FDA
Erythromycin
The FDA lists this product in 55 strengths and forms.
Composition
- Active ingredients
- ERYTHROMYCIN 2%
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- ERYTHROMYCIN 333MG · Tablet, delayed releaseANDA210954-002 · Prescription
- ERYTHROMYCIN 500MG · Tablet, delayed releaseANDA210954-003 · Prescription
- ERYTHROMYCIN 250MG · Tablet, delayed releaseANDA210954-001 · Prescription
- ERYTHROMYCIN 250MG · TabletANDA213628-001 · Prescription
- ERYTHROMYCIN 500MG · TabletANDA213628-002 · Prescription
- ERYTHROMYCIN 250MG · TabletANDA214549-001 · Prescription
- ERYTHROMYCIN 500MG · TabletANDA214549-002 · Prescription
- ERYTHROMYCIN 250MG · TabletANDA215661-001 · Prescription
- ERYTHROMYCIN 500MG · TabletANDA215661-002 · Prescription
- ERYTHROMYCIN 2% · SolutionANDA208100-001 · Discontinued
- ERYTHROMYCIN 500MG · TabletANDA209720-002 · Discontinued
- ERYTHROMYCIN 250MG · TabletANDA209720-001 · Discontinued
- ERYTHROMYCIN 250MG · TabletANDA212015-001 · Prescription
At a glance
- Brand name
- Erythromycin
- Route
- Topical
- Dosage form
- Solution
- Applicant
- Fougera Pharms
- Status
- Discontinued
- FDA approval
- 30 Sept 1997
- Application
- ANDA064187-001